Extended titration periods, where you spend 6 to 8 weeks at each dose rather than the standard 4 weeks, are supported by the clinical literature and can dramatically improve tolerability
The true risk could be barely above baseline or it could be substantially elevated, the data simply cannot pin it down with precision
The batch-specific CoA for BPC-157 + TB-500 shows an HPLC purity of 99% or higher, identity confirmation via mass spectrometry, the batch number and the net peptide content in milligrams per vial
6) ...but it looks like Pfizer is confident of "doing a Lipitor" and overtaking CagriSema post-2030 with what they consider to be a highly differentiated asset 7) Novo and Amgen share prices relatively unchanged so far, even though this announcement may most directly impact the opportunity for CagriSema and MariTide, through placing Pfizer's muscle, CV expertise and direct-to-patient capabilities behind these assets (this post does not constitute financial or investment advice) What are your reflections and questions on the deal
Taking a higher or lower dose than prescribed can also worsen the side effects of semaglutide